RESEARCHER PROFILE
Fernando Tomas Lanas
← Back to Universidad de La Frontera
F
Universidad de La Frontera
Fernando Tomas Lanas works in Cardiovascular Health and Risk Factors, Blood Pressure and Hypertension Studies, Acute Ischemic Stroke Management, Atrial Fibrillation Management and Outcomes, Diabetes, Cardiovascular Risks, and Lipoproteins. Recorded institutional associations include Universidad de La Frontera, Hospital Doctor Hernán Henríquez Aravena.
452Publications
53,399Citations
89H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
2004 · 12,018 citationsDulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · 3,129 citationsRivaroxaban with or without Aspirin in Stable Cardiovascular Disease
2017 · 2,436 citationsApixaban in Patients with Atrial Fibrillation
2011 · 2,433 citationsGlobal and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study
2016 · 2,284 citationsModifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
2019 · 2,000 citationsAssociations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study
2017 · 1,101 citationsCardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries
2014 · 981 citationsUse of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
2011 · 966 citationsUrinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events
2014 · 887 citationsAssociation of Urinary Sodium and Potassium Excretion with Blood Pressure
2014 · 858 citationsRivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
2017 · 754 citationsVariations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study
2019 · 651 citationsFruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
2017 · 646 citationsDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · 633 citationsSocioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study
2019 · 618 citationsEfficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial
2012 · 573 citationsDronedarone in High-Risk Permanent Atrial Fibrillation
2011 · 544 citationsAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
2016 · 484 citationsSafety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
2019 · 483 citationsFive-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting
2016 · 432 citationsAssociation of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study
2018 · 429 citationsGlobal mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
2017 · 409 citationsAvailability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
2015 · 392 citationsAssociation of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
2022 · 386 citations
